Location:

Local - Connecticut

Add to Favorites Subscribe Share
fbshare-Local - Connecticut

Showing results

110 of 265
Newswise: Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Yale Cancer Center

Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.

Channels: All Journal News, Cancer, Infectious Diseases, Local - Connecticut,

Released:
19-Feb-2019 2:20 PM EST
Open in New Tab
Comment
Newswise: Danbury Hospital: Minimally Invasive Procedure Heals Woman’s Heart

Danbury Hospital: Minimally Invasive Procedure Heals Woman’s Heart

Western Connecticut Health Network

An 86-year old woman from Danbury, Connecticut had Transcatheter Aortic Valve Replacement (TAVR) to treat severe aortic stenosis. TAVR is a minimally invasive procedure that is a safe alternative for patients who are at intermediate to high risk of complications from open heart surgery.

Channels: Cardiovascular Health, Heart Disease, Local - Connecticut,

Released:
5-Feb-2019 9:15 AM EST
Open in New Tab
Comment
Feature

Research reveals strategies for combating science misinformation

Yale School of Forestry & Environmental Studies

Just as the scientific community was reaching a consensus on the dangerous reality of climate change, the partisan divide on climate change began to widen.

Channels: All Journal News, Climate Science, Environmental Science, Government/Law, Nature, Nature (journal), Local - Connecticut,

Released:
14-Jan-2019 12:40 PM EST
Open in New Tab
Comment
Feature
Newswise: Yale Cancer Center scientists advise caution in immunotherapy research
  • Embargo expired:
    20-Dec-2018 11:00 AM EST

Yale Cancer Center scientists advise caution in immunotherapy research

Yale Cancer Center

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets.

Channels: All Journal News, Cancer, Cell Biology, Immunology, Respiratory Diseases and Disorders, Cell (journal), Local - Connecticut,

Released:
19-Dec-2018 12:05 PM EST
Open in New Tab
Comment
Research Results
Newswise: Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma
  • Embargo expired:
    8-Nov-2018 4:00 PM EST

Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma

Yale Cancer Center

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients.

Channels: All Journal News, Cancer, Dermatology, Immunology, Local - Connecticut,

Released:
8-Nov-2018 11:05 AM EST
Open in New Tab
Comment
Research Results
Newswise: Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Yale Cancer Center

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.

Channels: Cancer, Healthcare, Local - Connecticut, All Journal News,

Released:
7-Nov-2018 9:30 AM EST
Open in New Tab
Comment
Research Results
Newswise: Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

Yale Cancer Center

U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is the most commonly used option, but evidence for HU treatment is limited and both treatments are underused. Now, researchers at Yale Cancer Center have documented reduced risk of death and incidence of blood clots in patients receiving those therapies.

Channels: All Journal News, Blood, Cancer, Local - Connecticut,

Released:
5-Nov-2018 5:05 PM EST
Open in New Tab
Comment
Research Results
Newswise: Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Yale Cancer Center

Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.

Channels: Cancer, Neuro, Local - Connecticut,

Released:
5-Nov-2018 10:45 AM EST
Open in New Tab
Comment
Research Results

Showing results

110 of 265

Chat now!
1.55508